Literature DB >> 12592393

Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.

Xabier Agirre1, José Luis Vizmanos, María J Calasanz, Marina García-Delgado, María J Larráyoz, Francisco J Novo.   

Abstract

It has been shown that methylation of CpG dinucleotides located in the promoter region of TP53 is associated with low expression levels of this gene. We have analysed the methylation status of one CpG dinucleotide and of three CCWGG motifs, also located in the promoter region of the gene, in bone marrow samples obtained from patients with acute lymphoblastic leukemia (ALL). Eight out of 25 samples analysed showed methylation of either the CpG dinucleotide, the CCWGG motifs or both. Relative to nonmethylated leukemia samples, TP53 expression levels were decreased in all methylated samples in which TP53 expression could be measured. Methylation of CpG and CCWGG motifs in the promoter of TP53 could represent a novel mechanism leading to functional impairment of this tumor suppressor gene in ALL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592393     DOI: 10.1038/sj.onc.1206236

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines.

Authors:  Feng-Xian Zhai; Xiang-Fu Liu; Rui-Fang Fan; Zi-Jie Long; Zhi-Gang Fang; Ying Lu; Yong-Jiang Zheng; Dong-Jun Lin
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-18       Impact factor: 4.553

2.  Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5'-flanking region: a priming effect on the spreading of active demethylation.

Authors:  Andrea Fuso; Giampiero Ferraguti; Francesco Grandoni; Raffaella Ruggeri; Sigfrido Scarpa; Roberto Strom; Marco Lucarelli
Journal:  Cell Cycle       Date:  2010-10-29       Impact factor: 4.534

Review 3.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

Review 4.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

5.  TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status.

Authors:  Dorota Jesionek-Kupnicka; Malgorzata Szybka; Beata Malachowska; Wojciech Fendler; Piotr Potemski; Sylwester Piaskowski; Dariusz Jaskolski; Wielislaw Papierz; Wieslaw Skowronski; Waldemar Och; Radzislaw Kordek; Izabela Zawlik
Journal:  DNA Cell Biol       Date:  2014-02-07       Impact factor: 3.311

6.  Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.

Authors:  Elena N Voropaeva; Tatyana I Pospelova; Mikhail I Voevoda; Vladimir N Maksimov; Yuriy L Orlov; Olga B Seregina
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

7.  Genome-wide study of DNA methylation alterations in response to diazinon exposure in vitro.

Authors:  Xiao Zhang; Andrew D Wallace; Pan Du; Simon Lin; Andrea A Baccarelli; Hongmei Jiang; Nadereh Jafari; Yinan Zheng; Hehuang Xie; Marcelo Bento Soares; Warren A Kibbe; Lifang Hou
Journal:  Environ Toxicol Pharmacol       Date:  2012-08-01       Impact factor: 4.860

8.  Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.

Authors:  Maria E Figueroa; Shann-Ching Chen; Anna K Andersson; Letha A Phillips; Yushan Li; Jason Sotzen; Mondira Kundu; James R Downing; Ari Melnick; Charles G Mullighan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

Review 9.  Epigenetic regulation of male fate commitment from an initially bipotential system.

Authors:  S Alexandra Garcia-Moreno; Michael P Plebanek; Blanche Capel
Journal:  Mol Cell Endocrinol       Date:  2018-02-02       Impact factor: 4.102

10.  Methylation in the p53 promoter in epithelial ovarian cancer.

Authors:  Marcela Chmelarova; E Krepinska; J Spacek; J Laco; M Beranek; V Palicka
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.